Togafitiga o fa'ama'i fa'ama'i ma'i ile corona e...?

O se faʻataʻitaʻiga a le falemaʻi, o faʻaiʻuga na faʻasalalau, i le Aso Lulu, i se tusi talaaga faʻapitoa faʻafomaʻi, na faʻaalia ai o le vailaʻau "tofacitinib" mo le togafitiga o le maʻi gugu na faʻaalia ai ni taunuuga manuia i le togafitia o tagata mamaʻi ma faʻailoga ogaoga o le faʻamaʻi Covid-19.

Ma o le faʻataʻitaʻiga falemaʻi, o faʻaiʻuga na lomia i le "New England Journal of Medicine," na faia i luga o le 289 tagata na togafitia i falemaʻi i nofoaga eseese e 15 i Pasila ona o auga ogaoga o Covid-19.

O le afa o nei gasegase na tuʻuina atu i ai le tofacitinib (lua 10 mg tablets i aso taʻitasi) faʻatasi ma le soifua maloloina masani ma le isi afa na tuʻuina atu i ai se placebo ma le soifua maloloina tutusa.

Ina ua uma le 28 aso, 18% o le vaega na mauaina le vailaʻau na atiaʻe le faaletonu o le manava (faʻataʻitaʻiga e manaʻomia le intubation poʻo le avanoa i se manava) pe na maliliu, faʻatusatusa i le 29% o le vaega placebo.

I mea uma, 5.5% o tagata maʻi placebo na maliliu, faʻatusatusa i le 2.8% i le vaega tofacitinib.

Tofacitinib o loʻo faʻatau atu i lalo o ituaiga eseese, e aofia ai Zeljans, lea e umia e le American pharmaceutical group Pfizer.

"Ua faʻamalosia i matou i uluaʻi faʻaiʻuga o le matou faʻataʻitaʻiga faʻataʻitaʻiga o le tofacitinib i tagata mamaʻi i falemaʻi i le niumonia na mafua mai i le Covid-19," o le tala lea a Otavio Berwanger, o se fomaʻi i le Albert Einstein Hospital i Isaraelu na faʻatautaia le faʻataʻitaʻiga faʻataʻitaʻi i le faiga faapaaga ma Pfizer.

Tofacitinib ua faʻamaonia mo le faʻaaogaina i le Iunaite Setete e togafitia ai le gasegase o le rūmatoid, psoriatic arthritis, ma le ulcerative colitis.

Isi mataupu: 

E faapefea ona e feutagaʻi ma se tasi e lē amanaʻia oe ma le poto?

http://عشرة عادات خاطئة تؤدي إلى تساقط الشعر ابتعدي عنها